Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

Circulation Research

Volumn 78, Issue 3, 1996, Pages 415-423

  Campbell, William B ^a   Gebremedhin, Debebe ^b   Pratt, Phillip F ^b   Harder, David R ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

arachidonic acid; cytochrome P450; K+ channels; membrane potential; smooth muscle

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CHARYBDOTOXIN; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENZYME INHIBITOR; EPOXYICOSATRIENOIC ACID; ICOSATRIENOIC ACID; METHACHOLINE; MICONAZOLE; POTASSIUM CHANNEL; POTASSIUM ION; PROADIFEN; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HYPERPOLARIZATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

EID: 0030051805     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.3.415     Document Type: Article

References (42)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
2. Rubanyi GM. Endothelium-derived relaxing and contracting factors. J Cell Biol. 1991;46:27-36.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43: 109-142.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
5. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93: 515-524.
6. Bolton TB, Clapp LH. Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol. 1986;87:713-723.
7. Komori K, Suzuki H. Electrical responses of smooth muscle cells during cholinergic vasodilation in the rabbit saphenous artery. Circ Res. 1987;61:586-593.
8. Komori K, Suzuki H. Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery. Br J Pharmacol. 1987;92: 657-664.
9. Huang AH, Busse R, Bassenge E. Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide). Naunyn Schmiedebergs Arch Pharmacol. 1988;338:438-442.
10. + conductance. Circ Res. 1989;65:199-204.
11. Keef KD, Bowen SM. Effect of ACh on electrical and mechanical activity in guinea pig coronary arteries. Am J Physiol. 1989;257: H1096-H1103.
12. Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to N-nitro-L-arginine in rats. Am J Physiol. 1992;263:H1090-H1094.
13. Hwa JJ, Ghibaudi L, Williams P, Chatterjii M. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am J Physiol. 1994;266:H952-H958.
14. Chen G, Yamamoto Y, Miwa K, Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am J Physiol. 1991;260:H1888-H1892.
15. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, Fujishima M. Decreased endothelium-dependent hyperpolarizations to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992;70:660-669.
16. Taylor SG, Southerton JS, Weston AH, Baker JRJ. Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol. 1988;94: 853-863.
17. Weston AH, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol. 1992;43:47-54.
18. Van de Voorde J, Vanheel B, Leusen I. Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ Res. 1992;70:1-8.
19. Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol. 1992;105:429-435.
20. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
21. Archer SL, Huang JMC, Hampl V, Nelson DP, Schultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 1994;91:7583-7587.
22. Miyoshi H, Nakaya Y, Moritoki H. Nonendothelial-derived nitric oxide activates the ATP-sensitive K channel of vascular smooth muscle cells. FEBS Lett. 1994;345:47-49.
23. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990;346:69-71.
24. Rosolowsky M, Campbell WB. Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
25. Rosolowsky M, Campbell WB. Synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids by cultured bovine coronary artery endothelial cells. Biochem Biophys Acta. In press.
26. Rosolowsky M, Falck JR, Willerson JT, Campbell WB. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res. 1990;66: 608-621.
27. Rosolowsky M, Falck JR, Campbell WB. Synthesis and biological activity of epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Adv Prostaglandin Thromboxane Leukot Res. 1990;21:213-216.
28. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 1990;87: 682-685.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193: 265-275.
30. Revtyak GE, Hughes MJ, Johnson AR, Campbell WB. Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells. Am J Physiol. 1988;255:C214-C225.
31. Campbell WB, Brady MT, Rosolowsky LJ, Falck JR. Metabolism of arachidonic acid by rat adrenal glomerulosa cells: synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Endocrinology. 1991;128:2183-2194.
32. Harder DR. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ Res. 1984;55:197-202.
33. Gebremedhin D, Ma Y-H, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 1992;263: H519-H525.
34. Pfister SL, Campbell WB. Arachidonic acid- and acetylcnoline-induced relaxations of rabbit aorta. Hypertension. 1992;20:682-689.
35. Henrich WL, McAllister EA, Smith PB, Campbell WB. Guanosine 3′,5′-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol. 1988;255:F474-F478.
36. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res. 1995;32:79-92.
37. Abraham NG, Pinto A, Mullane KM, Levere RD, Spokas E. Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension. 1985;7:899-904.
38. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond). 1994;481:407-414.
39. Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: are there two relaxing mediators? Circ Res. 1987; 61(suppl II):II-61-II-67.
40. Gimenez-Gallego M, Navia MA, Reuben JP, Katz GM, Kaczorowski GJ, Garcia ML. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci USA. 1988;85:3329-3333.
41. + channel inhibitor. J Pharmacol Exp Ther. 1990;255:697-706.
42. + channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats. Br J Pharmacol. 1993;108:214-222.